ROBYN DE STEFANO: Open Payments
NPI 1073613261 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 16 payments from 6 companies in 2025. Trend: 2023 $35 · 2024 $74 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $148 |
| GENZYME CORPORATION | 6 | $141 |
| GlaxoSmithKline, LLC. | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: DUPIXENT, NUCALA, TAKHZYRO, NEFFY, TEZSPIRE.
Industry payments across AZ — which companies pay providers there.
